10 Questions With Merrill Lynch Healthcare Manager Jordan Schreiber

Health care and biotechnology funds are up a whopping 38.9% since Jan. 1 -- almost double runner-up real estate funds.

Biotech shops -- cutting edge drug makers -- have been hot, but many big-cap pharmaceuticals have struggled. What's ahead for the only sector fund category that's kept last year's pace? We huddled with Jordan Schreiber, who's managed (MAHCX Quote)Merrill Lynch Healthcare since 1983. That gives him the longest tenure of any current health care fund manager. He thinks the sector might cool, but sees good things ahead next year and his most recent buy for his own portfolio was a financial stock. Read on.

Jordan Schreiber
Fund (MAHCX Quote)Merrill Lynch Healthcare
Managing Fund Since April 4, 1983
Asset Size $706 million
1-Year Return / % Rank in Category 50.2% / 51%
5-Year Return/ % Rank in Category 27.9% / 15%
Load / Annual Expense Ratio 5.25% (class A shares) / 1.26%
Top Holdings HCA-The Healthcare Co. (HCA Quote) QLT Phototherapeutics (QLTI Quote) Stryker (SYK Quote)
Source: Morningstar. Holdings as of June 30. Performance as of Aug. 9.

...